Ascendis Pharma A (ASND) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Ascendis Pharma A (ASND) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 29.47% |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 26.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.52% |
| Dec 31, 2025 | -96.11% |
| Sep 30, 2025 | 63.93% |
| Jun 30, 2025 | 52.58% |
| Mar 31, 2025 | 53.88% |
| Dec 31, 2024 | -4,577.26% |
| Sep 30, 2024 | 26.71% |
| Jun 30, 2024 | 11.17% |
| Mar 31, 2024 | 83.56% |
| Dec 31, 2023 | -26.33% |
| Sep 30, 2023 | -68.45% |
| Jun 30, 2023 | -57.03% |
| Mar 31, 2023 | 55.33% |
| Dec 31, 2022 | 38.37% |
| Sep 30, 2022 | -26.49% |
| Jun 30, 2022 | -64.82% |
| Mar 31, 2022 | 56.60% |
| Dec 31, 2021 | 29.75% |
| Sep 30, 2021 | -28.49% |
| Jun 30, 2021 | -26.02% |